-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The synthesis of 5′-Adenylic acid, monoanhydride with phosphorothioic acid, trilithium salt is a critical step in the production of various chemicals and pharmaceuticals.
The demand for these compounds has been increasing steadily due to their widespread use in various industrial and medical applications.
The synthesis of 5′-Adenylic acid, monoanhydride with phosphorothioic acid, trilithium salt is a complex multi-step process that requires careful control of reaction conditions and purification of the final product.
The synthesis of 5′-Adenylic acid, monoanhydride with phosphorothioic acid, trilithium salt involves several steps, including the activation of the ribose ring, the deprotection of the 2′-O-Bn group, and the formation of the anhydride.
Each step in the process requires careful selection of reagents and conditions to ensure the desired product is obtained in high yield and with good purity.
One of the key steps in the synthesis of 5′-Adenylic acid, monoanhydride with phosphorothioic acid, trilithium salt is the activation of the ribose ring.
This step involves the conversion of the ribose ring to an activated derivative, such as a halide or a tosylate, which can then undergo further reactions to form the desired product.
The choice of activation method will depend on the specific reaction conditions and the desired product.
After the activation of the ribose ring, the next step is the deprotection of the 2′-O-Bn group.
This step involves the removal of the 2′-O-Bn protecting group, which is used to protect the fragile hydroxyl group during the earlier steps of the synthesis.
The deprotection step can be carried out using various reagents, such as methyl iodide or methyl tosylate, depending on the specific reaction conditions.
The final step in the synthesis of 5′-Adenylic acid, monoanhydride with phosphorothioic acid, trilithium salt is the formation of the anhydride.
This step involves the reaction of the activated ribose ring with phosphorothioic acid, trilithium salt under carefully controlled conditions.
The reaction conditions, such as the temperature and the solvent used, must be carefully optimized to ensure the desired product is obtained in high yield and with good purity.
After the synthesis of 5′-Adenylic acid, monoanhydride with phosphorothioic acid, trilithium salt, the final product must be purified to remove any impurities that may have been introduced during the synthesis process.
This purification step is critical to ensure that the final product meets the required purity levels for use in various industrial and pharmaceutical applications.
The synthesis of 5′-Adenylic acid, monoanhydride with phosphorothioic acid, trilithium salt is a complex multi-step process that requires careful control of reaction conditions and purification of the final product.
The growing demand for these compounds in various industrial and medical applications highlights the importance of this synthesis route and the need for further research and development in this area.
With the continued improvement of synthesis methods and purification techniques, it is likely that the production of 5′-Adenylic acid, monoanhydride with phosphorothioic acid, trilithium salt will become more efficient and cost-effective in the future.